214470-33-4 Usage
General Description
4-Chloro-7-methoxy-6-nitro-quinoline-3-carbonitrile is a chemical compound with the molecular formula C11H6ClN3O3. It is a quinoline derivative with a chloro, methoxy, nitro, and carbonitrile group attached to the quinoline ring. 4-Chloro-7-methoxy-6-nitro-quinoline-3-carbonitrile is used in organic synthesis and pharmaceutical research as a building block for the synthesis of various biologically active molecules. Its chemical properties make it useful in the development of new drugs and in the study of biological processes. Additionally, it may have potential applications in the field of medicinal chemistry and drug discovery. However, further research is needed to fully understand the potential uses and effects of 4-Chloro-7-methoxy-6-nitro-quinoline-3-carbonitrile.
Check Digit Verification of cas no
The CAS Registry Mumber 214470-33-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,4,7 and 0 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 214470-33:
(8*2)+(7*1)+(6*4)+(5*4)+(4*7)+(3*0)+(2*3)+(1*3)=104
104 % 10 = 4
So 214470-33-4 is a valid CAS Registry Number.
InChI:InChI=1/C11H6ClN3O3/c1-18-10-3-8-7(2-9(10)15(16)17)11(12)6(4-13)5-14-8/h2-3,5H,1H3
214470-33-4Relevant articles and documents
4-quinazoline amine derivatives and their use
-
Paragraph 0300; 0311-0313, (2017/01/31)
A 4-quinazoline amine derivative as represented by formula (1), a pharmaceutical composition comprising the derivative, and an application thereof in preparing medicine for curing cancer. The cancer is a drug-resistant cancer, preferably a cancer resisting an EGFR reversible inhibitor, and more preferably, a cancer resisting gefitinib, erlotinib or lapatinib; alternatively, the cancer carries EGFR mutation.
USE OF CYANOQUINOLINES FOR TREATING OR INHIBITING COLONIC POLYPS
-
, (2008/06/13)
This invention provides a method of treating or inhibiting colonic polyps which comprises providing a compound of formula (1); wherein R1, R2, R3, R4, X, Y, and n are defined hereinbefore, or a pharmaceutically acceptable salt thereof.
TRICYCLIC PROTEIN KINASE INHIBITORS
-
Page/Page column 69, (2010/02/04)
This invention provides compounds of Formula (I), where A'', Z, X and n are defined herein, or a pharmaceutically acceptable salt thereof which are useful as antineoplastic agents and in the treatment of polycystic kidney disease.
